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Purpose: High-density lipoproteins (HDL) are atheroprotective. New evidence shows that HDL
has widespread actions, including protection against cardiac ischemia reperfusion injury (IRI). This car-
dioprotective role has been attributed to several constituents of the HDL particle, including apolipo-
protein A1 (apoA1) the major protein constituent and sphingosine-1-phosphate (S1P). However, the
exact mechanisms of HDL-induced cardioprotection are still unknown and are under intensive inves-
tigation. Aparticular unresolved question remains the specific role of theHDL receptor, ScavengerRe-
ceptor BI (SR-BI), in the heart. The latter mediates many of the intracellular effects of HDL.
The aim of this study was to evaluate the specific role of SR-BI in the protective impact of HDL on the
heart.
Methods andResults: The effects of HDL on the heart was evaluated in vitro using rat cultured neo-
natal cardiomyocytes and ex vivo in mice using the isolated heart Langendorff model of IRI (global no
flow ischemia 35min, reperfusion 60min). In this model, HDL (400mg/mL) was injected during the first
7min of reperfusion and infarct size was assessed by triphenyltetrazolium chloride (TTC) staining. The
specific role of SR-BI was investigated in vitro using specific siRNA facilitated knockdown and ex vivo
using SR-BI knockout (SR-BI KO) mice.
We confirmed that SR-BI is expressed in the cardiomyocytes and that HDL binds specifically to these
cells. Treatment of cardiomyocytes with HDL induced the activation of several prosurvival signalling
proteins, including Akt, STAT3 and ERK1/2 and protected the cells against oxidative stress induced
by doxorubicin. Although specific binding of HDLwas significantly reduced in SR-BI knockdown cardi-
omyocytes, activation of the prosurvival pathwayswas not affected. Similarly, SR-BI knockdowndid not
reduce the in vitro protective influence of HDL against oxidative stress induced by doxorubicin.
Ex vivo, IRI induced an infarct size of 17.3+0.6% in isolated hearts of wildtype mice. HDL treatment
during the first phase of reperfusion significantly reduced the infarct size by approximately 35%
(p,0.05). This protective effect induced by HDL is maintained in SR-BI KO mice (40% of infarct size
reduction (p,0.05) compared to non-treated SR-BI-KO mice).
Conclusion: This is the first time that the specific role of SR-BI in the impact of HDL on the heart is
investigated. Our results do not support a role for the HDL receptor SR-BI in the protective influence
of HDL. Further investigations will be required to elucidate the exact mechanisms of HDL-induced
cardioprotection.
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